B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Exelixis

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Exelixis, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

hematoxylin
2 shared targets
bemcentinib
3 shared targets
merestinib
2 shared targets
bms
3 shared targets
cabozantinib
3 shared targets
glesatinib
2 shared targets
bastadin
2 shared targets
maleimide
2 shared targets
mk
2 shared targets
sotrastaurin
2 shared targets
Loading evidence profile...

This evidence profile for Exelixis is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.